Key signaling pathways (such as phosphoinositide 3-kinase, Myc, and RAS) act as sensors of energy, stress, and nutrient availability and integrate these inputs to directly control ribosome production and gene expression at the translational level. This activity is normally directly coupled to cell growth, division, and survival. However, it remains poorly understood the extent to which changes in ribosome number and nucleolar integrity downstream of these key signaling pathways contribute to their oncogenic activity. Emerging studies provide interesting insight into how deregulations in RNA polymerase I activity may lead to tumorigenesis and suggest that new drugs targeting ribosomal DNA transcription may hold great promise for the treatmen...
For over 100 years, pathologists have utilised an increase in size and number of nucleoli, the subnu...
The production and processing of ribosomal RNA is a complex and well-coordinated nucleolar process f...
While new cancer treatments continue to improve patient outcomes, for some cancers there have been l...
AbstractThe contribution of the nucleolus to cancer is well established with respect to its traditio...
The contribution of the nucleolus to cancer is well established with respect to its traditional role...
The nucleolus is the most prominent nuclear substructure assigned to produce ribosomes ; molecular m...
The nucleoli are the site of the production of ribosomes, the protein synthetic apparatus of the cel...
Ribosomes are macromolecular ribonucleoprotein complexes assembled from RNA and proteins. Functional...
Background: Recent studies have highlighted the fundamental role that key oncogenes such as MYC, RAS...
Multifaceted relations link ribosome biogenesis to cancer. Ribosome biogenesis takes place in the nu...
The nucleolus is the cellular site of ribosome biosynthesis. At this site, active ribosomal DNA (rDN...
The nucleolus has been known for a long time to fulfill crucial functions in ribosome biogenesis, of...
International audienceThe nucleolus is a distinct compartment of the nucleus responsible for ribosom...
The nucleolus is a distinct sub-cellular compartment structure in the nucleus. First observed more t...
The nucleolus is the major site for synthesis of ribosomes, complex molecular machines that are resp...
For over 100 years, pathologists have utilised an increase in size and number of nucleoli, the subnu...
The production and processing of ribosomal RNA is a complex and well-coordinated nucleolar process f...
While new cancer treatments continue to improve patient outcomes, for some cancers there have been l...
AbstractThe contribution of the nucleolus to cancer is well established with respect to its traditio...
The contribution of the nucleolus to cancer is well established with respect to its traditional role...
The nucleolus is the most prominent nuclear substructure assigned to produce ribosomes ; molecular m...
The nucleoli are the site of the production of ribosomes, the protein synthetic apparatus of the cel...
Ribosomes are macromolecular ribonucleoprotein complexes assembled from RNA and proteins. Functional...
Background: Recent studies have highlighted the fundamental role that key oncogenes such as MYC, RAS...
Multifaceted relations link ribosome biogenesis to cancer. Ribosome biogenesis takes place in the nu...
The nucleolus is the cellular site of ribosome biosynthesis. At this site, active ribosomal DNA (rDN...
The nucleolus has been known for a long time to fulfill crucial functions in ribosome biogenesis, of...
International audienceThe nucleolus is a distinct compartment of the nucleus responsible for ribosom...
The nucleolus is a distinct sub-cellular compartment structure in the nucleus. First observed more t...
The nucleolus is the major site for synthesis of ribosomes, complex molecular machines that are resp...
For over 100 years, pathologists have utilised an increase in size and number of nucleoli, the subnu...
The production and processing of ribosomal RNA is a complex and well-coordinated nucleolar process f...
While new cancer treatments continue to improve patient outcomes, for some cancers there have been l...